Weight-loss drug increases depression risk

Advice to assess obese patients for depression before being given weight loss drug rimonabant has been reiterated following evidence linking the drug with mental problems.

Findings of a meta-analysis of four trials carried out by Danish researchers showed patients given rimonabant were 2.5 times more likely to stop treatment because of depression than those on placebo. Patients were also three times more likely to quit treatment because of anxiety.

The four trials included a total of 4,105 patients who were randomly assigned 20mg rimonabant daily or placebo. Patients suffering from depressed mood were excluded from the trial.

Patients given the drug had 4.7kg greater weight loss after the first year than those on placebo. The rate of serious adverse events was 40 per cent higher in the treatment group.

In July the EMEA said rimonabant should be contraindicated in those with depression or those on antidepressants.

Dr David Haslam, clinical director of the National Obesity Forum, said GPs need to consider these contraindications before prescribing rimonabant.

A spokeswoman for manufacturer Sanofi-Aventis said it 'has actively sought to ensure that treatment is prescribed to the right patient'.

rachel.liddle@haymarket.com

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

RCGP online exhibition celebrates women in general practice

RCGP online exhibition celebrates women in general practice

An online exhibition celebrating women’s contribution to general practice over the...

MPs back campaign against reforms that 'threaten fairness of fitness to practise cases'

MPs back campaign against reforms that 'threaten fairness of fitness to practise cases'

Plans to scrap the 'five-year rule' and categorise doctors with health concerns as...

GP appointments up 31% compared with pre-pandemic levels

GP appointments up 31% compared with pre-pandemic levels

General practice in England delivered 31% more appointments in June this year than...

COVID-19 vaccine map: Which CCGs have most fully-vaccinated adults?

COVID-19 vaccine map: Which CCGs have most fully-vaccinated adults?

Tens of millions of COVID-19 jabs have been administered across England, but progress...

RCGP demands emergency rescue package for 'crisis-torn' general practice

RCGP demands emergency rescue package for 'crisis-torn' general practice

A five-point rescue plan for general practice drawn up by the RCGP warns the profession...